by reading this recent news release by Dow Jones.
Baxter International Inc. (BAX) said Wednesday that European Union regulators have approved its Celvapan vaccine for the H1N1, or swine, flu virus. The vaccine uses Baxter's new cell-based culturing technology, which can produce influenza vaccine within 12 weeks. Current flu vaccine technologies generally have a production run time of between four and six months. Baxter added that it will be conducting ongoing studies tracking the safety and performance of the vaccine in both adults and children. The company said initial human studies show the vaccine is safe and well-tolerated in recipients aged 18 or older.
-Val Brickates Kennedy; 415-439-6400; AskNewswires@dowjones.com
QUESTION: Just who were these vaccines tested on?
I guess if you already received your first vaccine, YOU
are the guinea pigs, ie lab rats, ferrets. How are you
feeling since? Please do not get sick, you have no
legal recourse if you do, nor does your family, if you
die. Your government has signed away your rights...
Why?
Now watch this video report with Dr. Leonard Horowitz.
In fact the European Union regulators mentioned
above in the Dow Jones news release and the EU
mentioned in the following video report by Dr.
Horowitz are both one in the same. Watch for
similar financial and official approvals printed
and promoted releases by our own Center For
Disease Control (CDC) and FDA.
No comments:
Post a Comment